Separate MMR shots are the goal of an executive order President Donald Trump signed Monday, directing federal agencies to pursue separate measles, mumps and rubella vaccines and, where feasible, recommend that childhood immunizations be given at separate medical visits.
Separate MMR shots are not currently available in the United States. The order says the combined MMR vaccine should be divided only “once such products are domestically available.” It also preserves access to existing combination vaccines.
That distinction separates a signed policy direction from an immediate change in a doctor’s office. Trump has told the federal health bureaucracy where he wants the schedule to go. The Department of Health and Human Services now has to explain how it could get there.
Table of Contents
Separate MMR shots and the three recommendation categories
The White House order places immunizations into three groups.
The universally recommended group covers measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus and varicella.
A second group covers certain high-risk populations. It includes respiratory syncytial virus monoclonal antibodies, hepatitis A, hepatitis B, meningococcal vaccines and dengue.
A third group relies on shared clinical decision-making. That category includes hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza and COVID-19. Hepatitis A and B appear in both the high-risk and shared-decision groups because the recommendation depends on the patient and circumstances.
The order directs every executive department and agency to review those categories and take appropriate steps allowed by law.
HHS has 90 days to plan separate MMR shots
Trump gave the HHS Task Force on Safer Childhood Vaccines 90 days to present plans to the White House.
The assigned work starts with options for administering MMR as three single vaccines. The task force may work with private companies and other countries, but it must guarantee continued availability of combination products.
The order also tells HHS to assess vaccine timing and sequencing, study alternatives to aluminum adjuvants, compare safety and efficacy, continue risk-benefit reviews and improve safety monitoring and transparency.
Those instructions create measurable questions for the agency. Can manufacturers supply separate products? What evidence would support more medical visits? What would separate appointments cost families in time, transportation and copays? The signed order does not answer those questions.
The Associated Press reported that public-health experts worry wider spacing can leave children vulnerable before a later appointment. AP also reported that combination vaccines undergo rigorous study and that U.S. research has linked combination shots with higher completion of recommended vaccinations by age two.
State school requirements do not change automatically
States, not the federal government, set the vaccination rules children must meet to attend school.
Trump’s order advises states and territories to review their requirements and consider changes based on the new federal categories. It does not itself repeal or rewrite a state law.
The order also tells the attorney general to support legal challenges to state laws when the administration considers those challenges meritorious and connected to parental authority, religious freedom, disability accommodations or equal protection. The Justice, Education and Health departments are instructed to police the same obligations among contractors and grant recipients.
That section could produce litigation even before separate MMR products reach the market. Its effect will depend on the cases the Justice Department chooses, the laws being challenged and the judges who hear them.
Cassidy breaks with Trump
Sen. Bill Cassidy of Louisiana, a physician and the Republican chairman of the Senate health committee, publicly rejected the order.
Cassidy wrote that the order was wrong, said Trump lacked the expertise to make the changes and stated that vaccines do not cause autism. His response put the dispute inside the Republican Party and inside the Senate committee responsible for health policy oversight.
Dr. Andrew Racine, president of the American Academy of Pediatrics, also disputed Trump’s recommendations. He told AP that vaccine science and efficacy had not changed and argued that the prior recommendations should remain.
Trump described his action as a victory for parental rights and what he calls gold-standard science. His order acknowledges that earlier administration changes were delayed by litigation over the federal vaccine advisory committee and schedule updates.
The next concrete deadline is now set. HHS owes Trump an implementation plan by November 8. Until then, the combined MMR vaccine remains available, separate MMR shots remain unavailable in the United States, and state school laws remain in force.
For more breaking policy news and analysis, visit 4Liberty Network
Leave a Reply